Article
Improving Therapeutic Decision-Making through Risk-stratification of Severe COVID-19 Patients
2024-08-26
Abstract excerpt
<title>Abstract</title> <p>The advent of cellular therapies, particularly the use of SARS-CoV-2-specific T cells (CoV-2-STs), offers a promising avenue for the treatment of severe COVID-19. Presice stratification of COVID-19 patients is essential to identify those at high risk who may benefit from intensive therapeutic strategies. Utilizing longitudinal biomarker data from a randomized phase 1–2 trial which was i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d15dc00-8bb1-544c-a44a-63436c2bcf54
- DOI
- 10.21203/rs.3.rs-4785410/v1
